Conformis, Inc. to Participate in Upcoming Investor Conferences – GlobeNewswire

December 31, 2020 08:30 ET | Source: Conformis, Inc.

BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in two virtual investor conferences in January 2021.

39thAnnual JP Morgan Healthcare Conference

H.C. Wainwright Bioconnect 2021 Conference

AboutConformis, Inc.

Conformisis a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit and conform to each patients unique anatomy.Conformisoffers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals.

In clinical studies, the Conformis iTotal CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints. For more information, visit http://www.comformis.com. To receive future releases in e-mail alerts, sign up at http://ir.conformis.com.

Billerica, Massachusetts, UNITED STATES

Formats available:

See the rest here:
Conformis, Inc. to Participate in Upcoming Investor Conferences - GlobeNewswire